The global pharmaceutical industry experienced an 18% decline in the number of microbiome-related patent applications in Q2 2023 compared with the previous quarter. The total number of microbiome-related grants dropped by 33% in Q2 2023, according to GlobalData’s Patent Analytics. GlobalData’s Microbiome-Targeting Therapeutics in Infectious Diseases – Thematic Research report provides information on market classification by therapy and technologies, regulatory and market access details for live biotherapeutic products (LBP) in the US and 5EU, and product & company profiles. It helps identify which indications are the mo Buy the report here.
Smarter leaders trust GlobalData
Notably, the number of microbiome-related patent applications in the pharmaceutical industry was 102 in Q2 2023, versus 125 in the prior quarter.
The top five companies accounted for 20% of patenting activity
Analysis of patenting activity by companies shows that DSM-Firmenich filed the most microbiome patents within the pharmaceutical industry in Q2 2023. The company filed 8 microbiome-related patents in the quarter, compared with 9 in the previous quarter. It was followed by Givaudan with 6 microbiome patent filings, AOBiome (2 filings), and French National Institute of Health and Medical Research (2 filings) in Q2 2023.
See Also:
Patenting activity was driven by the US with a 43% share of total patent filings
The largest share of microbiome related patent filings in the pharmaceutical industry in Q2 2023 was in the US with 43%, followed by Japan (10%) and China (8%). The share represented by the US was 2% higher than the 42% share it accounted for in Q1 2023.
For further understanding of GlobalData's Microbiome-Targeting Therapeutics in Infectious Diseases – Thematic Research buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
